Roundup summary of recent digital health strategic partnerships: HealthJoy, Teladoc Health Launch Virtual Primary Care HealthJoy, a benefits navigation platform that amplifies employer benefit strategies expands its partnership with Teladoc Health to introduce virtual primary care. HealthJoy Virtual Primary Care, powered by Teladoc Health, provides a fully integrated primary care experience that supports members throughout their entire healthcare journey. The solution will further
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
Recent Digital Health Strategic Partnerships Roundup: Unite Us, careMESH, CareCloud, Others
St. Joseph’s Health Enhances Provider Communications with careMESH’s Healthcare Directory and User-Friendly Messaging Services New Jersey-based St. Joseph’s Health partners with careMESH to significantly expand the health system’s clinical communications reach to all community physicians, including digital access to electronic medical records. Using careMESH, St. Joseph’s will focus on several key areas, including: Streamlining external communications with community physiciansReducing
Read More
Sanofi & Flatiron Health Partner to Redesign Clinical Trial Experience for Sponsors
What You Should Know: Flatiron Health announced a new partnership today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology. The multi-study partnership between Sanofi and Flatiron will focus on improving clinical trial data acquisition, delivery, and quality through site-facing technology that digitally transfers data captured in the electronic health record (EHR) directly into the electronic data
Read More
Quest Diagnostics Acquires Haystack Oncology for $300M in Cash
What You Should Know: Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid in the early, accurate detection of residual or recurring cancer and better inform therapy decisionsUnder the terms of the agreement, Quest will pay $300 million in cash at closing, net of cash acquired, and up to an additional $150 million on achieving future performance
Read More
PathAI and ConcertAI Partner to Create Histopathology & Clinical RWD Solutions
What You Should Know: PathAI, a provider of AI-powered pathology, and ConcertAI, an AI software-as-a-service (SaaS) technology and real-world evidence (RWE) solutions for life sciences and healthcare, today announced a strategic partnership to launch a first-in-class quantitative histopathology and curated clinical real-world data (RWD) solution.The solution combines PathAI's PathExplore™ tumor microenvironment panel with ConcertAI's Patient360™ and RWD360™
Read More
Report: Prior Authorization for Biomarker Testing Leads to Treatment Delays For Cancer Patients
What You Should Know: Biomarker testing is a necessary tool in the advancing world of precision cancer treatment. According to a new survey released by CancerCare, a leading national cancer support organization, biomarker testing helped doctors tailor therapy for nearly all the respondent patients (93%) whose cancers were tested over the past three years. Two in 10 cancer patients (20%) surveyed were able to avoid unnecessary chemotherapy and/or radiation and 10% became eligible for
Read More
Notable Leverages GPT to Automate Patient Front Office Experience
What You Should Know: Notable, an intelligent automation company for healthcare, launches Patient AI, a solution leveraging large language models (LLMs) and GPT (the technology powering ChatGPT) to bring personalization at scale to healthcare.Using GPT to scan existing clinical documentation, this tech can detect missed diagnoses, identify lapsed insurance cards, incorrect addresses, eligible clinical trials, or costly care gaps in real-time across an entire patient population. How
Read More
Exec Hires: COTA Appoints First Chief Commercial Officer
What You Should Know: - COTA, Inc., an oncology real-world data and analytics company, today announced the appointment of Sandy Leonard as its first Chief Commercial Officer. - As CCO, Sandy will drive COTA’s life sciences growth strategy, prioritizing customer success and experience. More specifically, she will lead a team that is laser-focused on ensuring that pharmaceutical partners have the data assets, analytics, services, and support they need to develop life-saving
Read More
Biostage Raises $6M to Advance Clinical Trials
What You Should Know: Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock.The funds will be used to accelerate the clinical development of Biostage’s lead product candidate, the Biostage Esophageal Implant, or BEI. The FDA has approved a
Read More
ChatGPT Has Potential to Help Cirrhosis, Liver Cancer Patients, Cedars Sinai Study Reveals
What You Should Know: A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge, lifestyle and treatments for these conditions.The findings, published in the peer-reviewed journal Clinical and Molecular Hepatology, highlight the AI system’s potential to play a role in clinical practice. Helping
Read More